Literature DB >> 12080089

JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

Yan-Fen Hu1, Rong Li.   

Abstract

BRCA1 is involved in the regulation of multiple nuclear events including transcription. AD1, one of the two trans-activation domains in BRCA1, stimulates transcription in a cell context-dependent manner. Here, it is shown that BRCA1 interacts with Jun proteins via a coiled-coil motif in AD1 and the basic leucine zipper (bZIP) region of the Jun proteins. The Jun-interacting domain in BRCA1 is critical for AD1-mediated transcriptional activation. In particular, the strength of AD1 in transcriptional activation is limited by the JunB level and ectopic expression of JunB potentiates the transcriptional activity of AD1. Furthermore, JunB mRNA expression is down-regulated in many ovarian tumor tissues examined. Thus, the coiled-coil-mediated cooperation between BRCA1 and JunB may facilitate the function of these proteins in tissue-specific transcriptional regulation and tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080089      PMCID: PMC186344          DOI: 10.1101/gad.995502

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  37 in total

1.  BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression.

Authors:  T K MacLachlan; K Somasundaram; M Sgagias; Y Shifman; R J Muschel; K H Cowan; W S El-Deiry
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Transformation by ras modifies AP1 composition and activity.

Authors:  F Mechta; D Lallemand; C M Pfarr; M Yaniv
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

Review 3.  BRCA1, BRCA2, and DNA damage response: collision or collusion?

Authors:  H Zhang; G Tombline; B L Weber
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

4.  Transcriptional activation by BRCA1.

Authors:  M S Chapman; I M Verma
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

5.  BRCA1 is a component of the RNA polymerase II holoenzyme.

Authors:  R Scully; S F Anderson; D M Chao; W Wei; L Ye; R A Young; D M Livingston; J D Parvin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  BRCA1 regulates p53-dependent gene expression.

Authors:  T Ouchi; A N Monteiro; A August; S A Aaronson; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.

Authors:  K Somasundaram; H Zhang; Y X Zeng; Y Houvras; Y Peng; H Zhang; G S Wu; J D Licht; B L Weber; W S El-Deiry
Journal:  Nature       Date:  1997-09-11       Impact factor: 49.962

Review 8.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

9.  Factors associated with the mammalian RNA polymerase II holoenzyme.

Authors:  A S Neish; S F Anderson; B P Schlegel; W Wei; J D Parvin
Journal:  Nucleic Acids Res       Date:  1998-02-01       Impact factor: 16.971

10.  Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Authors:  A N Monteiro; A August; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

View more
  21 in total

1.  A novel model to characterize structure and function of BRCA1.

Authors:  Dong Lin; Reza Izadpanah; Stephen E Braun; Eckhard Alt
Journal:  Cell Biol Int       Date:  2017-10-25       Impact factor: 3.612

2.  Classification of BRCA1 missense variants of unknown clinical significance.

Authors:  C M Phelan; V Dapic; B Tice; R Favis; E Kwan; F Barany; S Manoukian; P Radice; R B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; T Caldes; M de la Hoya; S Lindquist; S V Tavtigian; D Goldgar; A Borg; S A Narod; A N A Monteiro
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

3.  Antithetic effects of MBD2a on gene regulation.

Authors:  Hidetoshi Fujita; Ryouji Fujii; Satoko Aratani; Tetsuya Amano; Akiyoshi Fukamizu; Toshihiro Nakajima
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.

Authors:  Yunzhe Lu; Tao Kang; Yanfen Hu
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-16       Impact factor: 4.292

Review 5.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

6.  Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.

Authors:  Sarah E Aiyar; Jian-long Sun; Ashley L Blair; Christopher A Moskaluk; Yun-zhe Lu; Qi-Nong Ye; Yuki Yamaguchi; Amitava Mukherjee; Da-ming Ren; Hiroshi Handa; Rong Li
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

7.  PAM14, a novel MRG- and Rb-associated protein, is not required for development and T-cell function in mice.

Authors:  Kaoru Tominaga; D Mitchell Magee; Martin M Matzuk; Olivia M Pereira-Smith
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR.

Authors:  Hyo Jin Kang; Hee Jeong Kim; Chi-Heum Cho; Yanfen Hu; Rong Li; Insoo Bae
Journal:  Cancer Chemother Pharmacol       Date:  2008-02-08       Impact factor: 3.333

9.  BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.

Authors:  H J Kang; Y W Yi; H J Kim; Y B Hong; Y S Seong; I Bae
Journal:  Cell Death Dis       Date:  2012-06-28       Impact factor: 8.469

10.  BRCA-1 depletion impairs pro-inflammatory polarization and activation of RAW 264.7 macrophages in a NF-κB-dependent mechanism.

Authors:  Maurilio da Silva Morrone; Nauana Somensi; Lucas Franz; Vitor de Miranda Ramos; Juciano Gasparotto; Helen Taís da Rosa; Marcelo Sartori; Fabrício Figueiró; Daniel Pens Gelain; Alfeu Zanotto-Filho; José Cláudio Fonseca Moreira
Journal:  Mol Cell Biochem       Date:  2019-08-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.